Emotion regulation in patients with cardiovascular disease: development and validation of the stress and anxiety regulation strategies scale (STARTS).


Journal

Anxiety, stress, and coping
ISSN: 1477-2205
Titre abrégé: Anxiety Stress Coping
Pays: England
ID NLM: 9212242

Informations de publication

Date de publication:
05 2021
Historique:
pubmed: 1 1 2021
medline: 30 11 2021
entrez: 31 12 2020
Statut: ppublish

Résumé

Anxiety and stress influence the onset and prognosis of cardiovascular disease (CVD), but little is known about what CVD patients do when experiencing stress/anxiety. This study aimed to identify the behavioral strategies CVD patients use to regulate these emotions. Instrumental and longitudinal. A theoretically-guided scale, the Stress and Anxiety Regulation Strategies (STARTS), was developed considering the target population's characteristics. CVD patients were recruited at three different points ( At T1 exploratory factor analysis was conducted (random sample 1). The validity of the most parsimonious three-factor solution was subsequently found via confirmatory factor analysis at T1 (random sample 2), T2, and T3, revealing good and stable model fit. The factors represented strategies differentiated by the type and level of activity required (passive, intellectual, and physical strategies). The scale showed good test-retest reliability and internal consistency. Correlation and regression analyses with positive and negative affect, psychological wellbeing (stress, anxiety, depression), and cardiac self-efficacy provided evidence for the validity of STARTS score. Physical and passive strategies showed opposite patterns. The scale shows adequate psychometric properties for assessing the strategies used by CVD patients to regulate stress and anxiety.

Sections du résumé

BACKGROUND AND OBJECTIVES
Anxiety and stress influence the onset and prognosis of cardiovascular disease (CVD), but little is known about what CVD patients do when experiencing stress/anxiety. This study aimed to identify the behavioral strategies CVD patients use to regulate these emotions.
DESIGN
Instrumental and longitudinal.
METHODS
A theoretically-guided scale, the Stress and Anxiety Regulation Strategies (STARTS), was developed considering the target population's characteristics. CVD patients were recruited at three different points (
RESULTS
At T1 exploratory factor analysis was conducted (random sample 1). The validity of the most parsimonious three-factor solution was subsequently found via confirmatory factor analysis at T1 (random sample 2), T2, and T3, revealing good and stable model fit. The factors represented strategies differentiated by the type and level of activity required (passive, intellectual, and physical strategies). The scale showed good test-retest reliability and internal consistency. Correlation and regression analyses with positive and negative affect, psychological wellbeing (stress, anxiety, depression), and cardiac self-efficacy provided evidence for the validity of STARTS score. Physical and passive strategies showed opposite patterns.
CONCLUSIONS
The scale shows adequate psychometric properties for assessing the strategies used by CVD patients to regulate stress and anxiety.

Identifiants

pubmed: 33380227
doi: 10.1080/10615806.2020.1866173
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

349-364

Auteurs

Rosario Castillo-Mayén (R)

Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
Department of Psychology, University of Córdoba, Córdoba, Spain.

Bárbara Luque (B)

Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
Department of Psychology, University of Córdoba, Córdoba, Spain.

Tamara Gutiérrez-Domingo (T)

Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
Department of Psychology, University of Córdoba, Córdoba, Spain.

Esther Cuadrado (E)

Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
Department of Psychology, University of Córdoba, Córdoba, Spain.

Alicia Arenas (A)

Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
Department of Social Psychology, University of Seville, Seville, Spain.

Sebastián Rubio (S)

Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
Department of Specific Didactics, University of Córdoba, Córdoba, Spain.

Gracia María Quintana-Navarro (GM)

Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, Córdoba, Spain.
CIBER Fisiopatologia de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

Javier Delgado-Lista (J)

Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
Lipids and Atherosclerosis Unit, Department of Internal Medicine, Reina Sofia University Hospital, Córdoba, Spain.
CIBER Fisiopatologia de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Medicine (Medicine, Dermatology and Otorhinolaryngology), University of Córdoba, Córdoba, Spain.

Carmen Tabernero (C)

Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain.
Instituto de Neurociencias de Castilla y León (INCYL), University of Salamanca, Salamanca, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH